In this briefing:
- ECM Weekly (2 March 2019) – Futu, Tiger Brokers, China Risun, China Tobacco, Zhejiang New Century
- Up Fintech (Tiger Brokers) Pre-IPO Quick Note – Much Too Reliant on IBKR
- Futu Holdings IPO Quick Note – Comparison with Tiger Brokers – Same Market, Different Economics
- China Risun (中国旭阳) IPO Quick Note: Past the Peak of Coking Cycle
- Dexin China (德信中国) Post IPO – Poor Trading Liquidity, Top Ten Placees Hold 76% of IPO Shares
1. ECM Weekly (2 March 2019) – Futu, Tiger Brokers, China Risun, China Tobacco, Zhejiang New Century
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for upcoming IPOs.
ECM activity seems to be picking up as we get more information on upcoming large IPOs in Hong Kong and the US.
Starting with Hong Kong, there are a handful of small ongoing IPOs such as Yincheng International Holdings (1902 HK), China Risun (1907 HK), and Zhejiang New Century Hotel Management Group (1158 HK). Yincheng, a small and highly levered property developer, will list next week on the 7th of March.
But, the upcoming IPOs are the ones that seem to be more exciting with the HKEX filing of ESR Cayman’s draft prospectus. The company is a logistics real estate developer backed by Warburg Pincus and was said to be seeking US$1.5bn in its IPO. There are also Global Switch and OneConnect which seemed to be one step closer to their IPO.
In the US, we are finally getting approvals after the government shutdown starting with the Tencent-backed Futu Holdings Ltd (FHL US) launching its IPO and it will be listing on the 8th of March.
Jumping on the broker IPO bandwagon, Jim Rogers-backed Up Fintech (TIGR US) has also filed with the SEC. Sumeet Singh had already compared the two companies in his note, Futu Holdings IPO Quick Note – Comparison with Tiger Brokers – Same Market, Different Economics.
There are also news reports that Luckin Coffee, a Starbucks competitor in China, has already tapped three banks for its US IPO.
Accuracy Rate:
Our overall accuracy rate is 72.2% for IPOs and 63.7% for Placements
(Performance measurement criteria is explained at the end of the note)
![](https://static-prod.smartkarma.com/images/media/000/080/726/original/Total-Deals-Since-Inception-Accuracy-Rate-Since-Inception-_chartbuilder%20%288%29.png?1551519228)
New IPO filings
- ESR Cayman (Hong Kong, ~US$1.5bn)
- Jinshang Bank (Hong Kong, ~US$500m)
- China Everbright Water (Hong Kong, >US$100m, dual-listing)
- Up Fintech/Tiger Brokers (the US, >US$100m)
Below is a snippet of our IPO tool showing upcoming events for the next week. The IPO tool is designed to provide readers with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up expiry, etc) for all the deals that we have worked on. You can access the tool here or through the tools menu.
![](http://www.smartkarma.com/assets/plugins/a3-lazy-load/assets/images/lazy_placeholder.gif)
News on Upcoming IPOs
- Global Switch Picks Banks for Over $1 Billion IPO
- Warburg Pincus-backed ESR files for Hong Kong IPO of up to $1.5 billion
- Ping An plans IPO of fintech unit in HK at $1.35b
- Starbucks’ China rival Luckin Coffee taps 3 banks for US IPO
Smartkarma Community’s this week Analysis on Upcoming IPO
- Up Fintech (Tiger Brokers) Pre-IPO Quick Note – Much Too Reliant on IBKR
- Futu Holdings IPO Quick Note – Comparison with Tiger Brokers – Same Market, Different Economics
- China Risun (中国旭阳) IPO Quick Note: Past the Peak of Coking Cycle
- Futu Holdings IPO – Given the Team, Execution, and Backers, Might Be Worth a Look at the Low-End
- China Tobacco Intl (HK) IPO: Proxy For the Chinese Cigarette Consumption
- New Century Hotel (浙江開元酒店) IPO Review – Higher ADR and RevPAR than Peers but Margins Fall Short
- Futu Holdings Pre-IPO – FY18 Updates And Quick Thoughts on Valuation
- Yincheng Intl (银城国际) IPO Quick Note: A Highly Levered Nanjing Developer Bet
2. Up Fintech (Tiger Brokers) Pre-IPO Quick Note – Much Too Reliant on IBKR
Up Fintech (TIGR US) plans to raise up to US$150m in its US listing. The company counts Xiaomi Corp (1810 HK) and Interactive Brokers Group, Inc (IBKR US) as its main investors.
While TIGR has grown at a stupendous pace over the past three years, it has been able to do so owing to IBKR doing most of the heavy lifting of execution and clearing. While its trying to change that now, nearly all the revenue is still being driven by its IBKR affiliation.
I’ve covered some of the aspects of TIGR’s model in Futu Holdings IPO Quick Note – Comparison with Tiger Brokers – Same Market, Different Economics. In this insight, I’ll take a quick look at the company’s performance and the issues highlighted above.
3. Futu Holdings IPO Quick Note – Comparison with Tiger Brokers – Same Market, Different Economics
Futu Holdings Ltd (FHL US) plans to raise up to US$130m in its US listing.
In my earlier insights, I looked at the company’s background, past financial performance and scored the deal on our IPO framework.:
- Futu Holdings Pre-IPO – Great Metrics but in a Commoditised Industry,
- Futu Holdings Pre-IPO – FY18 Updates And Quick Thoughts on Valuation, and
- Futu Holdings IPO – Given the Team, Execution, and Backers, Might Be Worth a Look at the Low-End
In this insight, I do a quick comparison of Futu versus Up Fintech (TIGR US) (aka Tiger Brokers) who is regarded as Futu’s main competitor in the space.
4. China Risun (中国旭阳) IPO Quick Note: Past the Peak of Coking Cycle
China Risun, a leading coking coal refining player in China, is seeking up to USD 243 million via a listing in Hong Kong. In this insight, we will discuss the following topics:
- Company’s business and the value chain of coking coal
- Industry backdrop of the coking coal processing industry in China
- Shareholders and investors
- Thoughts on valuation
5. Dexin China (德信中国) Post IPO – Poor Trading Liquidity, Top Ten Placees Hold 76% of IPO Shares
Dexin China Holdings (2019 HK) raised US$189m in at HK$2.80 per share, at the mid-point of its IPO price range. We have previously covered the IPO in:
- Dexin China (德信中国) Pre-IPO – Related Party Transactions and Partial Asset Listing
- Dexin China (德信中国) IPO Review – Key Issues Remain but 9M Results Showed Strong Growth.
In this insight, we will update on the deal dynamics, implied valuation, and include a valuation sensitivity table.
Get Straight to the Source on Smartkarma
Smartkarma supports the world’s leading investors with high-quality, timely, and actionable Insights. Subscribe now for unlimited access, or request a demo below.